CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

Pfizer raised its full-year profit forecast on Tuesday while reporting second-quarter results that topped Wall Street ...

Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of ...

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% ...

Pfizer Inc. (NYSE:PFE) reported in its fiscal Q1 2025 results that the first phase of its manufacturing optimization program ...

Pfizer (PFE) stock is rising after the company reported strong second-quarter earnings and lifted its full-year forecast ...

European shares were higher today. The eurozone's STOXX 600 rose 0.5%, while Spain's IBEX 35 Index surged 0.2%. London's FTSE ...

Pfizer expects full-year earnings in the range of $2.90 to $3.10 per share, with revenue in the range of $61 billion to $64 billion. This story was generated by Automated Insights ( ...

Pfizer Inc. (NYSE:PFE) will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.

Shares of Pfizer Inc. PFE slid 2.18% to $23.29 Thursday, on what proved to be an all-around dismal trading session for the ...

Intervention/Treatment: The study tested PF-07275315, an experimental drug administered as a single intravenous infusion. The purpose was to evaluate its safety profile and how it behaves in the body ...

Highlights,Pfizer Inc. declared a Q3 in early September.,The first phase of its program remains on track.,The company ...